PMTC 2013 : International Conference of Personalized Medicine and Targeted Therapies in Cancer
Call For Papers
The Scientific Committee welcomes the submission of abstracts for oral or poster presentations at PMTC2013 from professionals, researchers and students in the Personalized Medicine and Targeted Therapies in Cancer field and related subspecialties.
Deadline for abstract submission is 15 October 2012, 8pm local UAE time.
Tumor progression: basic and therapeutic aspects
Aberrant signaling pathways in malignancy
Novel targeted therapy in cancer
Pharmacogenomics, personalized diagnostics and medicine
Genome project on drug development and cancer therapy
Epigenetics and its impact on cancer therapy
By submitting the abstract, the author confirms and agrees to the following:
a. All authors approve submitting this work for presentation.
b. The authors have done the work reported in the abstract and take full responsibility for the contents.
c. The authors transfer all copyright ownership of the abstract to the PMTC2013.
d. The authors agree to confine their presentation to information in the abstract.
e. At least one author will be available to present the abstract if accepted for presentation.
f. The author will immediately notify the PMTC2013 Scientific Committee if they are unable to make a presentation or if the presenting author has to be changed.
g. The authors guarantee that clinical studies and any animal tests have proceeded with the official permission from the proper authorities.
h. All presenters will be responsible for their own registration fees, hotel and travel expenses. We regret that we cannot waive registration fees or cover expenses for any oral or poster presenters.
1 May 2012: Abstract submission opens for poster and oral presentations
15 Oct 2012: Deadline for abstract submission
15 Nov 2012: Abstract acceptance notification to first authors
1 Dec 2012: All presenting authors must be registered
Guidelines for Abstract Submission
A special criterion for accepting abstracts will be their topic as well as structure, content and degree of novelty.
Structure of the Abstract
The structure of the abstract should be as follows:
a. Background and Objectives
Please note that a maximum of 300 words is permitted. The titles and the names of the authors are excluded from this number and have to be entered separately. Tables should not be included in the abstract body.
Methods section should include type of statistical analysis done if applicable to the study.
|EMBC 2013 Annual International Conference of the IEEE Engineering in Medicine and Biology Society|
|CVTDSC 2013 Computer Vision Techniques for the Diagnosis of Skin Cancer (Springer, 2013)|
|DANTH 2013 The First International Workshop on Data Analytics for Targeted Healthcare|
|BioMed 2013 Biomedical Engineering|
|IJFIPM 2013 Int. J. of Functional Informatics and Personalised Medicine - Special Issue on: Bioinformatics|
|PersDB 2013 The 7th International Workshop on Personalized Access, Profile Management, and Context Awareness in Databases|